BenGeorgeMD

Oncology • Milwaukee, WI

Hematologic Oncology

Associate Professor of Medicine, William F. Stapp Endowed Chair, Director, Phase 1 Clinical Trials Program, Medical College of Wisconsin, Milwaukee

Join to view full profile

Dr. George is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. George's full profile

Already have an account?

Office
9200 W Wisconsin Ave
# Neoplast
Milwaukee, WI 53226
Phone+1 414-805-6800

Fax+1 414-805-0618

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2007 - 2010
Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 2005 - 2007
University of ToledoInternship, Internal Medicine, 2004 - 2005
University of Kerala Medical CollegeClass of 1999

Certifications & Licensure

WI State Medical License 2007 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29
Completed
Phase 2
First in Human Study of M4344 in Participants With Advanced Solid Tumors Start of enrollment: 2015 Jan 26
Completed
Phase 1
Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors Start of enrollment: 2018 Dec 26
Terminated
Phase 1
Study of GNX102 in Patients With Advanced Solid Tumors Start of enrollment: 2020 Jul 29
Terminated
Phase 1
Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements Start of enrollment: 2020 Mar 01
Active, not recruiting
Phase 3
Roles: Contact
Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses Start of enrollment: 2022 Dec 21
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma Start of enrollment: 2022 May 13
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes.
Sara E Beltran Ponce, Christina J Small, Talha Ahmad, Kishan Patel, Susan Tsai
Practical Radiation Oncology. 2024-09-07
1 citations
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review.
Kohei Shitara, Alfred Falcone, Marwan G Fakih, Ben George, Raghav Sundar
The Oncologist. 2024-05-03
7 citations
Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
Ben George, Olga Kudryashova, Andrey Kravets, Samih Thalji, Subramaniam Malarkannan
Gastroenterology. 2024-05-01

Lectures

Analysis of hematologic adverse events (HeAEs) in trifluridine/tipiracil (FTD/TPI)-treated patients (pts) with or without renal/hepatic impairment (RI/HI): Pooled safe...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker ResearchApril 27th, 2021
Schedule at A GlanceJune 8th, 2015
Understanding Precision MedicineAugust 25th, 2023